Trustworthy multimodal biosensing in cardiovascular health: integrating uncertainty, causality, and signal integrity for clinical reliability
Cardiovascular disease (CVD) monitoring increasingly relies on multimodal biosensors, including electrocardiography (ECG), photoplethysmography (PPG), and advanced imaging systems. While deep learning has enhanced the analytical capacity of these biosensors, the translation of multimodal sensing data into clinical practice is hindered by a trustworthiness gap. Current biosensing architectures often lack robustness to sensor noise, produce poorly calibrated confidence estimates, ignore physiological causality, and fail to align with clinician workflows. Employing a systematic narrative review methodology across PubMed, IEEE Xplore, Scopus, and arXiv (2018–2026), this paper synthesizes the literature around six interconnected challenge areas in biosensor data integration: uncertainty quantification and conflict resolution; handling missing and misaligned modalities; knowledge-guided representation and fusion; causal and evidential reasoning; robust clinical evaluation; and human-centered integration. We propose a taxonomy of fusion strategies based on their trustworthiness properties and identify critical limitations in current methodologies, such as the tendency of black-box transformers to exploit spurious correlations in sensor data and the brittleness of early fusion under distribution shift. Furthermore, we outline a comprehensive research roadmap emphasizing causal disentanglement, federated multimodal learning, and interactive clinician-AI loops. By bridging algorithmic innovation with biosensor reliability, this review provides a blueprint for developing reliable, interpretable, and equitable multimodal biosensing systems. However, we emphasize that while these technical directions are promising, prospective clinical validation, standardized regulatory benchmarks, and equitable dataset curation remain essential prerequisites before these systems can be considered clinically validated solutions capable of transforming cardiovascular care.
Authors
- Chen Zhong (ORCID: https://orcid.org/0000-0002-5936-7195)
- Lanfang Lei (ORCID: https://orcid.org/0009-0009-1426-8693)
- Muhammad Shehzad Khan
- Qaisar Khan
- Adeel Akram
- Wasim Ullah Khan
- Derrick Boateng
Institutions
- Department of Health (CN)
- City University of Hong Kong (HK)
- Yangtze University (CN)
- Donghua University (CN)
- Nanfang Hospital (CN)
- Yango University (CN)
- Nanfang College Guangzhou (CN)
Publication Details
- Journal
- Frontiers in Bioengineering and Biotechnology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fbioe.2026.1925414
- Primary Topic
- Non-Invasive Vital Sign Monitoring
- Type
- article
- Field-Weighted Citation Impact
- 0.00